Recent Posts

News, Blog, Product
Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants
Posted 24th February 2021

Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants

Read More
News , Investor
David Atkins joins the National Genomics Board as BIA SME representative
Posted 18th February 2021

David Atkins joins the National Genomics Board as BIA SME representative

Read More
News , Investor
Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology
Posted 3rd February 2021

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Read More
News
Congenica Contributes to Key Priority within UK Rare Disease Framework
Posted 27th January 2021

Congenica Contributes to Key Priority within UK Rare Disease Framework

Read More
News , Blog
Congenica Launches Patient Advocacy and Engagement Advisory Board
Posted 14th January 2021

Congenica Launches Patient Advocacy and Engagement Advisory Board

Read More
News , Investor
Congenica Local Cloud Solution to Enable High-quality, Scalable Genomic Analysis in China
Posted 12th January 2021

Congenica Local Cloud Solution to Enable High-quality, Scalable Genomic Analysis in China

Read More
News , Blog , Product , COVID
2020 – The Year of Healthcare Heroes and International Teamwork
Posted 14th December 2020

2020 – The Year of Healthcare Heroes and International Teamwork

Read More
News , Blog , Product
Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification
Posted 9th December 2020

Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification

Read More
News , Blog
Inclusion in AJHG “Year in Review” 2020
Posted 7th December 2020

Inclusion in AJHG “Year in Review” 2020

Read More
News , Investor
Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer
Posted 1st December 2020

Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer

Read More
News , Investor
Congenica Appoints Dr. Sam Roberts as Non-Executive Director
Posted 20th November 2020

Congenica Appoints Dr. Sam Roberts as Non-Executive Director

Read More
previous 1 ...
2 3 4 5 6
... 11 next
News , Blog , Product
Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants
Posted 24th February 2021

Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants

Read More
News , Investor
David Atkins joins the National Genomics Board as BIA SME representative
Posted February Feb 18th 2021

David Atkins joins the National Genomics Board as BIA SME representative

Read More
News , Investor
Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology
Posted February Feb 3rd 2021

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Read More
News
Congenica Contributes to Key Priority within UK Rare Disease Framework
Posted January Jan 27th 2021

Congenica Contributes to Key Priority within UK Rare Disease Framework

Read More
News , Blog
Congenica Launches Patient Advocacy and Engagement Advisory Board
Posted January Jan 14th 2021

Congenica Launches Patient Advocacy and Engagement Advisory Board

Read More
News , Investor
Congenica Local Cloud Solution to Enable High-quality, Scalable Genomic Analysis in China
Posted January Jan 12th 2021

Congenica Local Cloud Solution to Enable High-quality, Scalable Genomic Analysis in China

Read More
News , Blog , Product , COVID
2020 – The Year of Healthcare Heroes and International Teamwork
Posted December Dec 14th 2020

2020 – The Year of Healthcare Heroes and International Teamwork

Read More
News , Blog , Product
Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification
Posted December Dec 9th 2020

Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification

Read More
News , Blog
Inclusion in AJHG “Year in Review” 2020
Posted December Dec 7th 2020

Inclusion in AJHG “Year in Review” 2020

Read More
News , Investor
Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer
Posted December Dec 1st 2020

Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer

Read More
News , Investor
Congenica Appoints Dr. Sam Roberts as Non-Executive Director
Posted November Nov 20th 2020

Congenica Appoints Dr. Sam Roberts as Non-Executive Director

Read More
previous 1 ...
2 3 4 5 6
... 11 next
CE 60px-Conformité_Européenne - WHITE27001 RGB Tick 60x60 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2022 Congenica Ltd. Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.